- On May 31, 2018
Zephyr Valves have been clinically documented to improve patient outcomes. This may include significant improvements in lung function, exercise tolerance and quality of life metrics, as well as long-term survival benefits for severe emphysema patients. With over a decade of clinical experience, Zephyr Valves significantly improve the lives of patients who undergo treatment.
As with any medical procedure, there are risks associated with the Zephyr Valve and procedure. Risks include a temporary acute worsening of symptoms, pneumonia, increased mucus secretions, and wheezing. The risk of pneumothorax (air leak in the lung) is increased during the initial period post procedure. Your doctor will review these risks with you to help you understand them.